Drug Type Small molecule drug |
Synonyms incrementally modified drug(Addpharma), AD-221 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Primary hypercholesterolemia | Phase 3 | United States | 16 Nov 2021 | |
Hyperlipidemias | Preclinical | South Korea | 09 Jul 2024 |